Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
60.0%
% of FBT's 31 holdings also in BBP
29.5%
% of BBP's 65 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 2.9% | 2.1% | 2.1% |
|
ACADIA PHARMACEUTICALS INC | 3.6% | 1.9% | 1.9% |
|
GILEAD SCIENCES INC | 3.6% | 1.8% | 1.8% |
|
UNITED THERAPEUTICS CORP | 3.4% | 1.7% | 1.7% |
|
INTRA-CELLULAR THERAPIES INC | 3.7% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to BBP
|
NATERA INC | 4.2% |
|
CORCEPT THERAPEUTICS INC | 4.2% |
 |
ARGENX SE ADR | 3.8% |
|
CATALYST PHARMACEUTICAL PART | 3.6% |
|
REPLIGEN CORP | 3.6% |
|
WATERS CORP | 3.5% |
 |
ALKERMES PLC | 3.3% |
|
ILLUMINA INC | 3.3% |
|
EXELIXIS INC | 3.0% |
 |
GENMAB A/S SPONSORED ADR | 3.0% |
FBT Underweight Relative to BBP
|
MIRUM PHARMACEUTICALS, INC. | -2.4% |
|
TRAVERE THERAPEUTICS, INC. | -2.0% |
|
LIGAND PHARMACEUTICALS-CL B | -1.9% |
|
LEXICON PHARMACEUTICALS, INC. | -1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -1.9% |
|
BIOCRYST PHARMACEUTICALS INC | -1.8% |
|
IONIS PHARMACEUTICALS, INC. | -1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.8% |
|
TG THERAPEUTICS INC | -1.8% |
|
ADMA BIOLOGICS, INC. | -1.8% |